Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Thyroid Disorders
Does solid/trabecular type papillary thyroid carcinoma pathology confer a higher risk of recurrence and warrant radioactive iodine ablation therapy?
Related Questions
What are your thoughts on the possible correlation between Breast implants and thyroid autoimmune disorders / or thyroid cancer?
How do you determine when to treat versus monitor subclinical thyroid disease early in pregnancy in patients with a negative TPOAb?
Would you ever recommend radiofrequency ablation over surgery or radioiodine for a patient with an autonomously functioning thyroid nodule?
For Graves' disease patients undergoing radioactive iodine ablation, what is the preferred approach to steroid prophylaxis for Graves' orbitopathy?
If a patient requires more than 5 mg per day of methimazole long term do you recommend alternative treatment options such as radio-iodine ablation or surgery?
How far in advance of a nuclear medicine thyroid update and scan should thionamides be discontinued and does this duration vary based on radio-isotope used (i.e. technetium versus RAI 123)?
For patients with low risk, differentiated thyroid cancer, how do you navigate the decision between less aggressive treatments, such as lobectomy alone without radioactive iodine, and more aggressive strategies?
What factors do you consider when deciding between RFA and surgery for a patient with a benign thyroid nodule causing dysphagia?
Would you consider adding metformin to the regimen of a diabetic patient with a benign thyroid nodule to decrease its volume?
When, if ever, is it appropriate to switch from generic levothyroxine to brand name Synthroid?
